WuXi PharmaTech, Combined with U.S. Firm, Sets Sights on Global Market

BEIJING - Fresh after acquiring U.S. biologics firm AppTec Laboratory Services, WuXi PharmaTech is pushing to rapidly broaden its scope of operations and widen its customer base worldwide, according to WuXi CEO Li Ge

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip